Article Versions Notes

Chowdhury B, Garg S, Ni W, Sattler M, Sanchez D, Meng C, Akatsu T, Stone R, Forrester W, Harrington E, et al. Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma. Cancers. 2024; 16(7):1319. https://doi.org/10.3390/cancers16071319

Chowdhury, Basudev, Swati Garg, Wei Ni, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Richard Stone, William Forrester, Edmund Harrington, and et al. 2024. "Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma" Cancers 16, no. 7: 1319. https://doi.org/10.3390/cancers16071319

Chowdhury, B., Garg, S., Ni, W., Sattler, M., Sanchez, D., Meng, C., Akatsu, T., Stone, R., Forrester, W., Harrington, E., Buhrlage, S. J., Griffin, J. D., & Weisberg, E. (2024). Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma. Cancers, 16(7), 1319. https://doi.org/10.3390/cancers16071319